These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 6392119

  • 21. Hydrochlorothiazide-amiloride versus hydrochlorothiazide alone for essential hypertension: effects on blood pressure and serum potassium level.
    Larochelle P, Logan AG.
    Can Med Assoc J; 1985 Apr 01; 132(7):801-5. PubMed ID: 3884122
    [Abstract] [Full Text] [Related]

  • 22. Double-blind assessment of tienilic acid in essential hypertension.
    Freis ED.
    Postgrad Med J; 1979 Apr 01; 55 Suppl 3():92-7. PubMed ID: 388402
    [Abstract] [Full Text] [Related]

  • 23. [Experiences with a new hypouricemic diuretic (tienilic acid): comparison with hydrochlorothiazide].
    Furrer J, Vetter W, Siegenthaler W.
    Schweiz Med Wochenschr; 1978 Dec 09; 108(49):1983-7. PubMed ID: 373100
    [Abstract] [Full Text] [Related]

  • 24. Treatment of hypertension in the very old.
    Otterstad JE, Ruilope LM.
    Int J Clin Pract Suppl; 2000 Nov 09; (114):10-9. PubMed ID: 11221289
    [Abstract] [Full Text] [Related]

  • 25. Hydrochlorothiazide and bendroflumethiazide in low doses--a comparative trial.
    Acta Pharmacol Toxicol (Copenh); 1984 Nov 09; 54 Suppl 1():47-51. PubMed ID: 6369883
    [Abstract] [Full Text] [Related]

  • 26. Piretanide in the treatment of essential hypertension. A double-blind comparison versus placebo.
    Verho M, Rangoonwala B, Beloso M, Maass L, Bender R, Garduno D.
    Drugs Exp Clin Res; 1986 Nov 09; 12(5):385-91. PubMed ID: 3522159
    [Abstract] [Full Text] [Related]

  • 27. Serum trace-element levels in piretanide-treated hypertensives: a double-blind trial against hydrochlorothiazide plus amiloride.
    Verho M, Bossaller W, Heinen B.
    Int J Clin Pharmacol Res; 1987 Nov 09; 7(1):5-11. PubMed ID: 3294616
    [Abstract] [Full Text] [Related]

  • 28. Enalapril and enalapril-hydrochlorothiazide in the treatment of essential hypertension. The Enalapril-Hydrochlorothiazide in Essential Hypertension Canadian Working Group.
    Clin Ther; 1993 Nov 09; 15(2):364-73. PubMed ID: 8519044
    [Abstract] [Full Text] [Related]

  • 29. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May 09; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 30. Beta-blocker/thiazide combination for treatment of hypertensive children: a randomized double-blind, placebo-controlled trial.
    Sorof JM, Cargo P, Graepel J, Humphrey D, King E, Rolf C, Cunningham RJ.
    Pediatr Nephrol; 2002 May 09; 17(5):345-50. PubMed ID: 12042891
    [Abstract] [Full Text] [Related]

  • 31. Once daily treatment of mild to moderate hypertension with xipamid: a controlled study.
    Weber JC, Bird H, Cosh J, Davies PS, Dixon AS, Lister J, Petts HV, Prichard BN, Raftery EB.
    Br J Clin Pharmacol; 1977 Jun 09; 4(3):283-8. PubMed ID: 332217
    [Abstract] [Full Text] [Related]

  • 32. Once daily administration of low-dose xipamide: a long-term study in mild to moderate hypertension.
    Brochez A, Castro M, Odegaard A, Thomis J.
    Int J Clin Pharmacol Ther Toxicol; 1983 Aug 09; 21(8):394-8. PubMed ID: 6354942
    [Abstract] [Full Text] [Related]

  • 33. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
    Mugellini A, Dobovisek J, Planinc D, Cremonesi G, Fogari R.
    Clin Ther; 2004 Sep 09; 26(9):1419-26. PubMed ID: 15531004
    [Abstract] [Full Text] [Related]

  • 34. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
    Lindholm LH, Persson M, Alaupovic P, Carlberg B, Svensson A, Samuelsson O.
    J Hypertens; 2003 Aug 09; 21(8):1563-74. PubMed ID: 12872052
    [Abstract] [Full Text] [Related]

  • 35. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL, Glazer R, Weinberger M, Alvarado R, Huang J, Graff A.
    Clin Ther; 2007 Jan 09; 29(1):61-73. PubMed ID: 17379047
    [Abstract] [Full Text] [Related]

  • 36. Antihypertensive effectiveness of low-dose lisinopril-hydrochlorothiazide combination. A large multicenter study. Lisinopril-Hydrochlorothiazide Group.
    Chrysant SG.
    Arch Intern Med; 1994 Apr 11; 154(7):737-43. PubMed ID: 8147677
    [Abstract] [Full Text] [Related]

  • 37. Double-blind, randomized, cross-over clinical trial of metoprolol and propranolol in mild to moderate essential hypertension.
    Pandhi P, Sahai J, Wahi PL, Sharma BK, Sharma PL.
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar 11; 25(3):163-5. PubMed ID: 3549583
    [Abstract] [Full Text] [Related]

  • 38. [Controlled randomized double-blind study for the comparison of the treatment of patients with essential hypertension with homeopathic and with pharmacologically effective drugs].
    Hitzenberger G, Korn A, Dorcsi M, Bauer P, Wohlzogen FX.
    Wien Klin Wochenschr; 1982 Dec 24; 94(24):665-70. PubMed ID: 6763404
    [Abstract] [Full Text] [Related]

  • 39. Double-blind factorial trial of prindolol and hydrochlorothiazide in hypertension.
    Chalmers JP, Korner PI, Tiller DJ, Bune AJ, Steiner JD, West MJ, Wing LM, Uther JF.
    Med J Aust; 1976 May 01; 1(18):650-3. PubMed ID: 781495
    [Abstract] [Full Text] [Related]

  • 40. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components.
    MacKay JH, Arcuri KE, Goldberg AI, Snapinn SM, Sweet CS.
    Arch Intern Med; 1996 Feb 12; 156(3):278-85. PubMed ID: 8572837
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.